Zing Forum

Reading

Machine Learning-Based Diabetes Risk Prediction System: Model Optimization Practices in Medical Scenarios

This article introduces a machine learning project for predicting diabetes risk using real medical data, focusing on the application of KNN and Random Forest models in medical scenarios, with special attention to recall rate and false negative control.

机器学习医疗AI糖尿病预测KNN随机森林召回率疾病筛查健康科技假阴性医疗模型
Published 2026-06-07 20:16Recent activity 2026-06-07 20:25Estimated read 8 min
Machine Learning-Based Diabetes Risk Prediction System: Model Optimization Practices in Medical Scenarios
1

Section 01

Project Introduction: Practice of Machine Learning-Based Diabetes Risk Prediction System

Project Basic Information

Core Views

This project aims to build a diabetes risk prediction system using real medical data, focusing on the application of KNN and Random Forest models in medical scenarios, especially optimizing recall rate and controlling false negatives to meet the special needs of disease screening.

2

Section 02

Project Background and Challenges in Medical Scenarios

Project Background

Diabetes is one of the fastest-growing chronic diseases globally, and early risk identification is crucial for preventing complications. Traditional screening relies on invasive methods like fasting blood glucose testing, which are costly and require professional equipment. This project explores using machine learning to analyze routine health indicators for non-invasive, large-scale early warning in populations.

Core Challenges in Medical Scenarios

  1. High Cost of False Negatives: Missed diagnosis leads to patients missing the optimal intervention time and developing severe complications.
  2. Model Interpretability: Doctors need to understand the prediction logic to integrate it into clinical processes.
  3. Data Imbalance: Healthy people far outnumber patients, affecting model training performance.
3

Section 03

Technical Implementation Path

Data Processing and Feature Engineering

  • Data Preprocessing: Conduct exploratory data analysis (EDA), including data quality checks, distribution analysis, and correlation analysis (Pearson coefficient).
  • Feature Types: Cover physiological indicators (age, BMI, blood pressure), biochemical indicators (insulin, HbA1c, blood lipids), and lifestyle factors (family history, exercise/diet habits).

Model Selection and Optimization

KNN Algorithm

  • Advantages: No parametric assumptions, intuitive and easy to understand, sensitive to local patterns.
  • Medical Tuning: Cross-validation to select optimal K value, weighted distance, feature standardization.

Random Forest

  • Advantages: Built-in feature importance evaluation, anti-overfitting, handles high-dimensional data.
  • Optimization: Adjust number and depth of trees, OOB error estimation, feature importance identification.
4

Section 04

Model Evaluation from a Medical Perspective

Medical Priority of Evaluation Metrics

Confusion Matrix and Recall

Actual \ Predicted Predicted Diseased Predicted Healthy
Actually Diseased True Positive (TP) False Negative (FN) ⚠️
Actually Healthy False Positive (FP) True Negative (TN)

Recall formula: $Recall = \frac{TP}{TP + FN}$, which measures the model's ability to identify all patients and is a core indicator for medical screening.

Other Metrics

  • Precision: $Precision = \frac{TP}{TP + FP}$ (reduces unnecessary examinations).
  • F1 Score: Harmonic mean of recall and precision.
  • ROC Curve and AUC: Reflects the model's discrimination ability.

Threshold Tuning

  • Lower the threshold to improve recall.
  • Cost-sensitive learning (assign higher cost to false negatives).
  • Stratified thresholds (adjust by risk level).
5

Section 05

Practical Application Value and Limitations

Practical Application Value

  1. Early Screening Tool: Assist primary care units to quickly identify high-risk groups and prioritize glucose tolerance tests.
  2. Health Management Integration: Embed into corporate health platforms or insurance systems for automatic risk scoring.
  3. Public Health Decision-Making: Analyze population risk distribution to optimize prevention resource allocation.

Current Limitations

  1. Data Representativeness: Race and regional distribution in training data may limit generalization.
  2. Feature Completeness: Indicators like family history are difficult to obtain in a standardized way.
  3. Static Data: Based on single measurements, cannot capture dynamic changes in the condition.
6

Section 06

Future Improvement Directions and Conclusion

Future Improvement Directions

  1. Temporal Modeling: Use RNN/LSTM to process continuous monitoring data.
  2. Multimodal Fusion: Combine medical images like fundus photos to improve accuracy.
  3. Federated Learning: Integrate multi-center data under privacy protection.
  4. Causal Inference: Evolve from predictive models to intervention decision support.

Conclusion

This project demonstrates a typical application paradigm of medical AI, emphasizing the special needs of medical scenarios (recall rate, false negative control). Insights for developers:

  • Domain knowledge is key to modeling decisions.
  • Evaluation metrics should align with business scenarios (not just accuracy).
  • Models need to balance accuracy and interpretability.

With the popularity of wearable devices, such lightweight models will play a greater role in preventive medicine.